Pills and Politics
Americans’ Struggle for Affordable Medication
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Access a growing selection of included Audible Originals, audiobooks, and podcasts.
You will get an email reminder before your trial ends.
Audible Plus auto-renews for $7.95/mo after 30 days. Upgrade or cancel anytime.
Pills and Politics
Narrated by:
Virtual Voice
Buy for $3.99
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
-
Narrated by:
-
Virtual Voice
-
By:
-
Douglas Sims
This title uses virtual voice narration
Virtual voice is computer-generated narration for audiobooks.
About this listen
Despite widespread support for reform, both major political parties—Republicans and Democrats—are unlikely to implement the transformative changes needed. Their dependency on campaign contributions from pharmaceutical companies and industry lobbyists creates a powerful disincentive to challenge this broken system. As a result, the status quo remains firmly in place, where both parties benefit from Big Pharma’s contributions, leaving consumers to shoulder the financial burden.
Consequently, Americans disproportionately bear the cost of high drug prices, essentially subsidizing more affordable access to medications in other parts of the world. While citizens in other nations benefit from government-regulated pricing and cost controls, U.S. patients pay some of the highest prices globally. This disparity allows Big Pharma to rake in billions on the backs of Americans, while charging significantly less in countries where governments prioritize citizens' health over industry profits. In contrast, American politicians, often more focused on securing their next election and reliant on industry donations, fall short in addressing the long-term health and financial security of their constituents.
For meaningful change, the United States can draw valuable lessons from other countries that have successfully balanced innovation, affordability, and access. Policies that introduce government-led price negotiations, streamline pathways for generics and biosimilars, and enforce transparency in drug pricing could provide a pathway toward a more equitable system.
The future of prescription drug pricing in America requires unified action from all stakeholders—policymakers, healthcare providers, and the public. Policymakers must champion legislation that prioritizes patient access; healthcare providers need to advocate for affordable treatment options; and patients themselves are crucial advocates for change, driving grassroots movements that remind leaders of the urgent need for reform.
Though the journey toward a fairer, more affordable healthcare system is complex, the stakes are too high to ignore. By confronting the forces that inflate drug prices and championing reforms that prioritize public health, there is real potential to reshape the pharmaceutical landscape. The time for change is now—through commitment, collaboration, and informed action, the promise of affordable healthcare for all Americans can become a reality.
adbl_web_global_use_to_activate_webcro768_stickypopup